AstraZeneca sale haunts SA in third wave, but Kubayi stands by decision
It is more than 90% effective against hospitalisation from Delta variant which is ‘likely to blame’ for third wave
It was a contentious sale that haunts the country.
In mid-March the government sold about a million doses of the AstraZeneca (AZ) vaccine to other African nations after it emerged that its efficacy was substantially reduced by the Beta variant.
Now that the Delta variant is surging through SA, the AZ decision has reared its head again because an analysis by Public Health England (PHE) showed it offered protection of more than 90% against hospitalisation from the variant...